Video LectureTopics in Intraoperative Gynecologic Oncology

This is a lecture addressing gynecologic tumors and the importance of accurate intraoperative and postoperative pathologic results. We will discuss the nuances of specific pathologic findings that direct our approach to clinical management of the patient.

Originally presented on February 9, 2017 in Park City, Utah.



Lecture Presenter

Mark Dodson, MD

Mark Dodson, MD

Professor of Obstetrics and Gynecology
University of Utah School of Medicine

Mark K. Dodson, M.D., is a gynecological oncologist at the University of Utah. As a Gynecologic Oncology investigator, he treats gynecologic cancers and pre-cancers. His clinical research focuses on minimally invasive surgery and novel treatments of gynecologic malignancies and his expertise is in radical abdominal pelvic surgery with particular emphasis on minimally invasive surgery. His basic science research interests include drug delivery systems, particularly for treating ovarian cancer. Dr. Dodson received his medical degree from the Quillen School of Medicine at East Tennessee State University. He joined the University of Utah after completing his fellowship in gynecologic oncology at the Mayo Clinic in Rochester, Minnesota. He is the co-founder of the Susan Sandoval Run for Ovarian Cancer, an annual event sponsored by the University of Utah Department of Obstetrics and Gynecology, from which all proceeds are used to meet the goals of the Ovarian Cancer Education, Awareness and Research Fund. Dr. Dodson is also the founder of the Gynecologic Oncology Outreach Program at the Sletten Cancer Institute in Great Falls, MT.



Objectives

After this presentation, participants will be able to:

  • Develop a clear understanding of the depth of invasion that changes surgical approach to management in vulvar cancer.
  • Develop a clear understanding of the depth of invasion that changes the surgical procedure required in cervix cancer.
  • Identify the pathologic outcome that is expected by the clinician when resecting vulvar Paget’s disease.
  • Determine the importance of pathologic diagnosis on clinical management of young women with low malignant potential tumors.

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories